• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁酰胆碱酯酶反应性可区分衰老的淀粉样斑块与痴呆的淀粉样斑块。

Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia.

作者信息

Mesulam M M, Geula C

机构信息

Center for Behavioral and Cognitive Neurology, Northwestern University Medical School, Chicago, IL 60611.

出版信息

Ann Neurol. 1994 Nov;36(5):722-7. doi: 10.1002/ana.410360506.

DOI:10.1002/ana.410360506
PMID:7979218
Abstract

In a sample of consecutively received, 4 demented and 4 age-matched nondemented brains, the total cortical area covered by plaque-like A beta amyloid and butyrylcholinesterase deposits was measured at two regions of the temporal cortex with the help of computed densitometry. Demented as well as age-matched nondemented brains contained A beta and butyrylcholinesterase-positive plaques. The total cortical area covered by the A beta precipitates was higher in demented individuals but there was overlap with the values seen in the specimens from nondemented individuals. The proportional plaque area displaying butyrylcholinesterase reactivity was very significantly and five fold to sixfold higher in the demented than in the nondemented group and there was no overlap between the two populations. Diffuse A beta deposits in nondemented elderly brains may represent a benign or preclinical stage of plaque deposition with relatively little pathological effect on brain tissue and mental function. Our results suggest that the progressively more extensive butyrylcholinesterase reactivity of plaques may participate in their transformation from a relatively benign form to pathogenic structures associated with neuritic degeneration and dementia.

摘要

在一组连续接收的样本中,有4个痴呆患者的大脑和4个年龄匹配的非痴呆患者的大脑,借助计算机密度测定法,在颞叶皮质的两个区域测量了由斑块样β淀粉样蛋白和丁酰胆碱酯酶沉积物覆盖的总皮质面积。痴呆患者以及年龄匹配的非痴呆患者的大脑中均含有β淀粉样蛋白和丁酰胆碱酯酶阳性斑块。痴呆患者中由β淀粉样蛋白沉淀物覆盖的总皮质面积更高,但与非痴呆患者标本中的值存在重叠。显示丁酰胆碱酯酶反应性的斑块比例面积在痴呆组中比非痴呆组非常显著地高5到6倍,且两组之间没有重叠。非痴呆老年大脑中的弥漫性β淀粉样蛋白沉积物可能代表斑块沉积的良性或临床前期阶段,对脑组织和心理功能的病理影响相对较小。我们的结果表明,斑块中逐渐更广泛的丁酰胆碱酯酶反应性可能参与了它们从相对良性形式向与神经炎性变性和痴呆相关的致病结构的转变。

相似文献

1
Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia.丁酰胆碱酯酶反应性可区分衰老的淀粉样斑块与痴呆的淀粉样斑块。
Ann Neurol. 1994 Nov;36(5):722-7. doi: 10.1002/ana.410360506.
2
Butyrylcholinesterase in the life cycle of amyloid plaques.淀粉样斑块生命周期中的丁酰胆碱酯酶
Ann Neurol. 1997 Dec;42(6):909-18. doi: 10.1002/ana.410420613.
3
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.唐氏综合征中异质性淀粉样β肽和载脂蛋白E的沉积顺序:对淀粉样斑块形成初始事件的影响。
Neurobiol Dis. 1996 Feb;3(1):16-32. doi: 10.1006/nbdi.1996.0003.
4
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.衰老及轻度认知障碍中的神经原纤维缠结、淀粉样蛋白与记忆
Arch Neurol. 2003 May;60(5):729-36. doi: 10.1001/archneur.60.5.729.
5
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.人源和PS2APP小鼠脑内淀粉样沉积物中β淀粉样肽组成的高灵敏度分析
Neuroscience. 2006 Dec 1;143(2):461-75. doi: 10.1016/j.neuroscience.2006.08.027. Epub 2006 Sep 27.
6
A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.免疫组织化学和银染法检测老龄犬脑内弥漫性斑块的比较
Neurobiol Aging. 2006 Feb;27(2):293-305. doi: 10.1016/j.neurobiolaging.2005.02.017. Epub 2005 Jul 5.
7
[Cases of numerous diffuse plaques in the neocortex but without severe senile changes in the hippocampus].
Rinsho Shinkeigaku. 1990 Oct;30(10):1073-7.
8
Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.脑脊液tau蛋白与β-淀粉样蛋白(42)的比值作为非痴呆老年人认知衰退的预测指标
Arch Neurol. 2007 Mar;64(3):343-9. doi: 10.1001/archneur.64.3.noc60123. Epub 2007 Jan 8.
9
Pathological markers associated with normal aging and dementia in the elderly.与老年人正常衰老和痴呆相关的病理标志物。
Ann Neurol. 1993 Oct;34(4):566-73. doi: 10.1002/ana.410340410.
10
Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density.阿尔茨海默病及淀粉样斑块密度高的非痴呆个体中的淀粉样蛋白负荷与神经元件
Exp Neurol. 1996 Nov;142(1):89-102. doi: 10.1006/exnr.1996.0181.

引用本文的文献

1
Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer's Disease.新型吡唑啉-噻唑类化合物作为胆碱酯酶双靶点抑制剂治疗阿尔茨海默病的设计、合成及分子对接研究
ACS Omega. 2025 Aug 22;10(34):38427-38439. doi: 10.1021/acsomega.5c01055. eCollection 2025 Sep 2.
2
Photochemically Assisted Synthesis of Thienobenzotriazole-Based Dual Cholinesterase Inhibitors.基于噻吩并苯并三唑的双胆碱酯酶抑制剂的光化学辅助合成
Molecules. 2025 Aug 20;30(16):3439. doi: 10.3390/molecules30163439.
3
Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions.
探索阿尔茨海默病的治疗前景:当前策略与未来方向
Ibrain. 2025 May 10;11(2):162-184. doi: 10.1002/ibra.12197. eCollection 2025 Summer.
4
Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: implications in aging and Alzheimer's disease.正常与 Aβ 相关胆碱酯酶的差异衰老细胞溶解抑制作用:对衰老和阿尔茨海默病的影响
Aging (Albany NY). 2025 Mar 29;17(3):822-850. doi: 10.18632/aging.206227.
5
The Therapeutic Potential of (Lour.) Prain Essential Oil in Alzheimer's Disease: EEG Signal Analysis In Vivo, SH-SY5Y Cell Model In Vitro, and Network Pharmacology.(萝芙木)普雷恩精油在阿尔茨海默病中的治疗潜力:体内脑电图信号分析、体外SH-SY5Y细胞模型及网络药理学
Biology (Basel). 2024 Jul 18;13(7):544. doi: 10.3390/biology13070544.
6
Synthesis, characterization and biological evaluation of aurones as potential neuroprotective agents.奥瑞因类化合物的合成、表征及作为潜在神经保护剂的生物评价。
Future Med Chem. 2024 Aug 17;16(16):1649-1663. doi: 10.1080/17568919.2024.2363713. Epub 2024 Jun 28.
7
Targeting Alzheimer's Disease: Evaluating the Efficacy of C-1 Functionalized N-Aryl-Tetrahydroisoquinolines as Cholinergic Enzyme Inhibitors and Promising Therapeutic Candidates.靶向阿尔茨海默病:评估 C-1 功能化 N-芳基-四氢异喹啉类化合物作为胆碱能酶抑制剂和有前途的治疗候选物的疗效。
Int J Mol Sci. 2024 Jan 14;25(2):1033. doi: 10.3390/ijms25021033.
8
Monitoring Alzheimer's disease via ultraweak photon emission.通过超微弱光子发射监测阿尔茨海默病。
iScience. 2023 Dec 14;27(1):108744. doi: 10.1016/j.isci.2023.108744. eCollection 2024 Jan 19.
9
A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer's disease.一种用于高效评估阿尔茨海默病基于底物的胆碱酯酶成像探针的方法。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2225797. doi: 10.1080/14756366.2023.2225797. Epub 2023 Jun 26.
10
Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?β-淀粉样肽对乙酰胆碱酯酶的激活是否会降低胆碱酯酶抑制剂的效果?
Int J Mol Sci. 2023 Nov 16;24(22):16395. doi: 10.3390/ijms242216395.